Driving developments in UK oesophageal radiotherapy through the SCOPE trials
Author:
Publisher
Springer Science and Business Media LLC
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Link
http://link.springer.com/content/pdf/10.1186/s13014-019-1225-0.pdf
Reference33 articles.
1. Rackley T, Leong T, Foo M, et al. Definitive Chemoradiotherapy for Oesophageal Cancer, a promising start on an exciting journey. Clin Oncol. 2014;26:533–40.
2. Gwynne S, Wijnhoven B, Hulshof M, et al. Role of Chemoradiotherapy in Oesophageal Cancer - adjuvant and neoadjuvant therapy. Clin Oncol. 2014;26:522–32.
3. Crosby T, Hurt C, Falk S, et al. Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial. Lancet. 2013;14:627–37.
4. Mukherjee S, Hurt C, Gwynne S, et al. NEOSCOPE: a randomised Phase II study of induction chemotherapy followed by either oxaliplatin/capecitabine or paclitaxel/carboplatin. based chemoradiation as pre-operative regimen for resectable oesophageal adenocarcinoma. BMC Cancer. 2015;15:48.
5. SCOPE 2 Trials. 2017. https://clinicaltrials.gov/ct2/show/NCT02741856 . Accessed Jan 2019.
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Addressing challenges in low-income and middle-income countries through novel radiotherapy research opportunities;The Lancet Oncology;2024-06
2. The National Radiotherapy Trials Quality Assurance Group – Driving up Quality in Clinical Research and Clinical Care;Clinical Oncology;2024-05
3. The role of surgery or definitive chemoradiotherapy in management of localized squamous cell carcinoma of esophagus – What is the verdict?;Critical Reviews in Oncology/Hematology;2023-10
4. The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis;Cancer Biology & Therapy;2022-12-15
5. Volumetric modulated arc therapy (VMAT): a review of clinical outcomes—what is the clinical evidence for the most effective implementation?;The British Journal of Radiology;2022-08-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3